Oxurion NV (LTS:0G99) Total Equity: €-12.69 Mil (As of Dec. 2025)


LTS:0G99 Oxurion NV LTS:0G99
9 GF Score
Price €0.27
GF Value €0.91
! 7 Warning Signs
View Full Analysis

What is Oxurion NV Total Equity?

Oxurion NV LTS:0G99 9 Total Equity is €-12.69 Mil as of Dec. 2025. GuruFocus rates LTS:0G99 with a GF Score™ of 9/100 and a GF Value™ of €0.91. The stock has 7 warning signs investors should review.

Oxurion NV's total equity for the quarter that ended in Dec. 2025 was €-12.69 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Oxurion NV Total Equity Historical Data

* Premium members only.

The historical data trend for Oxurion NV's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxurion NV Total Equity Chart

Oxurion NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.11 -4.58 -13.19 -11.06 -12.69

Oxurion NV Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.19 -14.81 -11.06 -12.00 -12.69
LTS:0G99
9GF Score
Oxurion NV LTS:0G99
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oxurion NV Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Oxurion NV's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=3.825-16.514
=-12.69

Oxurion NV's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=3.825-16.514
=-12.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €-12.69 Mil mean?
Oxurion NV (LTS:0G99) has a Total Equity of €-12.69 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Oxurion NV and its competitors.
Is Oxurion NV's Total Equity too high?
Oxurion NV's current Total Equity is €-12.69 Mil. Overall, Oxurion NV has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Oxurion NV's Total Equity compare to VRTX and REGN?
Oxurion NV's Total Equity of €-12.69 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Oxurion NV and its competitors. Oxurion NV's current Total Equity is €-12.69 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxurion NV stock overvalued right now?
Oxurion NV (LTS:0G99) has a current Total Equity of €-12.69 Mil. The stock's GF Value™ is €0.91, compared to a current price of €0.27 — trading 70% below its estimated fair value. The current Total Equity is €-12.69 Mil. Oxurion NV's overall GF Score™ is 9/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Oxurion NV (LTS:0G99), the current Total Equity is €-12.69 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oxurion NV (LTS:0G99) Overvalued in 2026?

Based on GuruFocus' analysis, Oxurion NV stock appears to be undervalued. The current stock price of €0.27 is trading 70% below its estimated GF Value™ of €0.91.

Key valuation signals for LTS:0G99:

  • Total Equity: €-12.69 Mil
  • GF Value™: €0.91 vs. price of €0.27 (70% below fair value)
  • GF Score™: 9/100 with 7 warning signs

No single metric tells the full story. See the LTS:0G99 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oxurion NV Business Description

Other Exchanges TG40:GermanyOXUR:Belgium
Address Gaston Geenslaan 1, Leuven, BEL, B-3001
Oxurion NV is a holding company specializing in acquiring and integrating clinical research services companies (CROs) covering the full clinical research value chain across Europe.
9GF Score

Get the complete analysis for LTS:0G99

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.27
Price
€0.91
GF Value